Extreme rise of blood pressure may increase the risk associated with electroconvulsive therapy (ECT) in patients with cardiovascular disease, cerebrovascular disease, and aortic and intracranial aneurysms. A case is presented in which sublingual nifedipene was used in the treatment of a high-risk patient with severe rise of blood pressure. The therapeutic alternatives of managing severe ECT-related blood pressure increases are presented.